-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Johnson & Johnson, Lowers Price Target to $272

Benzinga·10/14/2026 20:44:22
Listen to the news
Leerink Partners analyst David Risinger maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $276 to $272.